Moderna slips as EU regulator cites more side effects possibly linked to COVID-19 shot

Seeking Alpha2021-08-12

Moderna, Inc. has dropped sharply for the second consecutive session as the European drugs regulator pointed to three more conditions developed by a small number of people after receiving the company’...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Melvinleong
2021-08-12
Melvinleong
Cry
Melvinleong
2021-08-12
Melvinleong
Cry
extralamer
2021-08-12
extralamer
lol
Korimerla
2021-08-12
Korimerla
Noted
- Korimerla:
  ok
- Wellyanto:
  Ok

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1161951421?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-08-12 08:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1161951421","market":"us","top_or_hot":-1,"title":"Moderna slips as EU regulator cites more side effects possibly linked to COVID-19 shot","media":"Seeking Alpha","content":"<div>\n<p>Moderna, Inc. has dropped sharply for the second consecutive session as the European drugs regulator pointed to three more conditions developed by a small number of people after receiving the company’...</p>\n\n<a href=\"https://seekingalpha.com/news/3729048-moderna-slips-as-eu-regulator-cites-more-side-effects-possibly-linked-to-covid-19-shot\">网页链接</a>\n\n</div>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna slips as EU regulator cites more side effects possibly linked to COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna slips as EU regulator cites more side effects possibly linked to COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-12 08:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3729048-moderna-slips-as-eu-regulator-cites-more-side-effects-possibly-linked-to-covid-19-shot><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna, Inc. has dropped sharply for the second consecutive session as the European drugs regulator pointed to three more conditions developed by a small number of people after receiving the company’...</p>\n\n<a href=\"https://seekingalpha.com/news/3729048-moderna-slips-as-eu-regulator-cites-more-side-effects-possibly-linked-to-covid-19-shot\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNTX","symbol_name":"BioNTech SE","start_time":0,"source_url":"https://seekingalpha.com/news/3729048-moderna-slips-as-eu-regulator-cites-more-side-effects-possibly-linked-to-covid-19-shot","article_id":"1161951421","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1161951421","pubTimestamp":1628728758,"sourceInfo":null,"weMediaInfo":null,"summary":"Moderna, Inc. has dropped sharply for the second consecutive session as the European drugs regulator","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BNTX":"BioNTech SE","MRNA":"Moderna, Inc.","PFE":"辉瑞"},"translate_title":"随着欧盟监管机构引用更多可能与新冠肺炎注射有关的副作用，莫德纳下滑","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"PFE":0.9},"content_text":"Moderna, Inc. has dropped sharply for the second consecutive session as the European drugs regulator pointed to three more conditions developed by a small number of people after receiving the company’s COVID-19 shot.\nThe Pharmacovigilance Risk Assessment Committee (PRAC) of European Medicines Agency (EMA) has started an assessment of Erythema multiforme, nephrotic syndrome, and glomerulonephritis experienced by some recipients of the vaccine.\nErythema multiforme is a form of allergic condition on the skin, nephrotic syndrome is a kidney disease affecting protein filtration, and glomerulonephritis affects tiny filters in kidneys.\nAs of July 29, a little over 43.5M doses of Moderna’s COVID-19 vaccine have been used in the region compared to more than 330M doses of the rival vaccine from Pfizer/BioNTech SE.\nThe regulator had requested more information from companies to establish a possible link but did not reveal the number of newly found cases. Moderna (MRNA) was not immediately available for Reuters’ request for comments.\nThe latest findings follow the warnings issued by the EU watchdog in July for messenger-RNA-based COVID-19 shots developed by Moderna (MRNA), Pfizer (PFE)/ BioNTech (BNTX) to indicate the rare cases of heart inflammation linked to the vaccines.\nAfter their recent peak, Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX) are all trading lower today.","kind":null,"is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":895749371,"gmtCreate":1628775641493,"gmtModify":1631892241562,"author":{"id":"4089547170637760","authorId":"4089547170637760","name":"Melvinleong","avatar":"https://static.tigerbbs.com/c77ae67b370b71710abcb7f140ebfe3e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4089547170637760","authorIdStr":"4089547170637760"},"htmlText":"Cry","listText":"Cry","text":"Cry","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/895749371","repostId":1161951421,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":895754149,"gmtCreate":1628775563181,"gmtModify":1631892241564,"author":{"id":"4089547170637760","authorId":"4089547170637760","name":"Melvinleong","avatar":"https://static.tigerbbs.com/c77ae67b370b71710abcb7f140ebfe3e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4089547170637760","authorIdStr":"4089547170637760"},"htmlText":"Cry","listText":"Cry","text":"Cry","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/895754149","repostId":1161951421,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":895835593,"gmtCreate":1628732669112,"gmtModify":1633744735989,"author":{"id":"3568957506130100","authorId":"3568957506130100","name":"extralamer","avatar":"https://static.tigerbbs.com/cb0f6d1bfc8423c5f9d4f57cb181aaba","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3568957506130100","authorIdStr":"3568957506130100"},"htmlText":"lol","listText":"lol","text":"lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/895835593","repostId":1161951421,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":895164977,"gmtCreate":1628729379399,"gmtModify":1633744793497,"author":{"id":"3566099162047280","authorId":"3566099162047280","name":"Korimerla","avatar":"https://static.tigerbbs.com/8b1e7ef47aacafc432f0fe3719112ea2","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3566099162047280","authorIdStr":"3566099162047280"},"htmlText":"Noted","listText":"Noted","text":"Noted","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/895164977","repostId":1161951421,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5500547,"gmtCreate":1628729417139,"gmtModify":1635153832983,"authorId":3566099162047280,"author":{"id":3566099162047280,"idStr":"3566099162047280","authorId":3566099162047280,"name":"Korimerla","avatar":"https://static.tigerbbs.com/8b1e7ef47aacafc432f0fe3719112ea2","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":895164977,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":5500584,"gmtCreate":1628729594496,"gmtModify":1635153829350,"authorId":3578723450181101,"author":{"id":3578723450181101,"idStr":"3578723450181101","authorId":3578723450181101,"name":"Wellyanto","avatar":"https://static.tigerbbs.com/da46836141f0e6c7ed8114362646057a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":895164977,"type":1,"supId":5500547,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":53,"commentSize":4,"repostSize":0,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1161951421"}